APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood-derived Products

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Blood-derived Products Market Outlook and Growth Opportunities 2026

23 December 2025195 pages

Choose your research edition.

Industry ResearchBlood-derived Products Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood-derived Products Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Blood-derived Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood-derived Products Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood-derived Products Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Blood-derived Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Blood-derived Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Blood-derived Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood-derived Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Blood-derived Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Blood-derived Products market include Yuanda Shuyang, Takeda, Weiguang Bio, Tiantan Bio, Shuanglin Bio, Shanghai RAAS, Hualan Bio, Boya Bio and CBPO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Blood-derived Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blood-derived Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood-derived Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Blood-derived Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Blood-derived Products Segment by Company

Yuanda Shuyang

Takeda

Weiguang Bio

Tiantan Bio

Shuanglin Bio

Shanghai RAAS

Hualan Bio

Boya Bio

CBPO

Octapharma

LFB Group

Kedrion

Grifols

CSL

Blood-derived Products Segment by Type

Coagulation Factors

Immunoglobulins

Albumin

Others

Blood-derived Products Segment by Application

Therapeutics

Excipient

Other

Blood-derived Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Blood-derived Products status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Blood-derived Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Blood-derived Products significant trends, drivers, influence factors in global and regions.

6. To analyze Blood-derived Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood-derived Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood-derived Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood-derived Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Blood-derived Products market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood-derived Products industry.

Chapter 3: Detailed analysis of Blood-derived Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Blood-derived Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Blood-derived Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Blood-derived Products Industry Trends Table 2. Blood-derived Products Industry Drivers Table 3. Blood-derived Products Industry Opportunities and Challenges Table 4. Blood-derived Products Industry Restraints Table 5. Global Blood-derived Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Blood-derived Products Revenue Share by Company (2021-2026) Table 7. Global Blood-derived Products Sales Volume by Company (t) & (2021-2026) Table 8. Global Blood-derived Products Sales Volume Share by Company (2021-2026) Table 9. Global Blood-derived Products Average Price (USD/kg) of Company (2021-2026) Table 10. Global Blood-derived Products Company Ranking, (2024-2026) & (USD Million) Table 11. Global Blood-derived Products Key Company Manufacturing Base & Headquarters Table 12. Global Blood-derived Products Company, Product Type & Application Table 13. Global Blood-derived Products Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Blood-derived Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Coagulation Factors Table 18. Significant Companies of Immunoglobulins Table 19. Significant Companies of Albumin Table 20. Significant Companies of Others Table 21. Global Blood-derived Products Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 22. Global Blood-derived Products Sales Volume by Type (2021-2026) & (t) Table 23. Global Blood-derived Products Sales Volume by Type (2027-2032) & (t) Table 24. Global Blood-derived Products Sales Volume Share by Type (2021-2026) Table 25. Global Blood-derived Products Sales Volume Share by Type (2027-2032) Table 26. Global Blood-derived Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Blood-derived Products Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Blood-derived Products Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Blood-derived Products Sales Value Share by Type (2021-2026) Table 30. Global Blood-derived Products Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Therapeutics Table 32. Significant Companies of Excipient Table 33. Significant Companies of Other Table 34. Global Blood-derived Products Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 35. Global Blood-derived Products Sales Volume by Application (2021-2026) & (t) Table 36. Global Blood-derived Products Sales Volume by Application (2027-2032) & (t) Table 37. Global Blood-derived Products Sales Volume Share by Application (2021-2026) Table 38. Global Blood-derived Products Sales Volume Share by Application (2027-2032) Table 39. Global Blood-derived Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Blood-derived Products Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Blood-derived Products Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Blood-derived Products Sales Value Share by Application (2021-2026) Table 43. Global Blood-derived Products Sales Value Share by Application (2027-2032) Table 44. Global Blood-derived Products Sales by Region: 2021 VS 2025 VS 2032 (t) Table 45. Global Blood-derived Products Sales by Region (2021-2026) & (t) Table 46. Global Blood-derived Products Sales Market Share by Region (2021-2026) Table 47. Global Blood-derived Products Sales by Region (2027-2032) & (t) Table 48. Global Blood-derived Products Sales Market Share by Region (2027-2032) Table 49. Global Blood-derived Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Blood-derived Products Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Blood-derived Products Sales Value Share by Region (2021-2026) Table 52. Global Blood-derived Products Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Blood-derived Products Sales Value Share by Region (2027-2032) Table 54. Global Blood-derived Products Market Average Price (USD/kg) by Region (2021-2026) Table 55. Global Blood-derived Products Market Average Price (USD/kg) by Region (2027-2032) Table 56. Global Blood-derived Products Sales by Country: 2021 VS 2025 VS 2032 (t) Table 57. Global Blood-derived Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Blood-derived Products Sales by Country (2021-2026) & (t) Table 59. Global Blood-derived Products Sales Market Share by Country (2021-2026) Table 60. Global Blood-derived Products Sales by Country (2027-2032) & (t) Table 61. Global Blood-derived Products Sales Market Share by Country (2027-2032) Table 62. Global Blood-derived Products Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Blood-derived Products Sales Value Market Share by Country (2021-2026) Table 64. Global Blood-derived Products Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Blood-derived Products Sales Value Market Share by Country (2027-2032) Table 66. Yuanda Shuyang Company Information Table 67. Yuanda Shuyang Business Overview Table 68. Yuanda Shuyang Blood-derived Products Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 69. Yuanda Shuyang Blood-derived Products Product Portfolio Table 70. Yuanda Shuyang Recent Development Table 71. Takeda Company Information Table 72. Takeda Business Overview Table 73. Takeda Blood-derived Products Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 74. Takeda Blood-derived Products Product Portfolio Table 75. Takeda Recent Development Table 76. Weiguang Bio Company Information Table 77. Weiguang Bio Business Overview Table 78. Weiguang Bio Blood-derived Products Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 79. Weiguang Bio Blood-derived Products Product Portfolio Table 80. Weiguang Bio Recent Development Table 81. Tiantan Bio Company Information Table 82. Tiantan Bio Business Overview Table 83. Tiantan Bio Blood-derived Products Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 84. Tiantan Bio Blood-derived Products Product Portfolio Table 85. Tiantan Bio Recent Development Table 86. Shuanglin Bio Company Information Table 87. Shuanglin Bio Business Overview Table 88. Shuanglin Bio Blood-derived Products Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 89. Shuanglin Bio Blood-derived Products Product Portfolio Table 90. Shuanglin Bio Recent Development Table 91. Shanghai RAAS Company Information Table 92. Shanghai RAAS Business Overview Table 93. Shanghai RAAS Blood-derived Products Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 94. Shanghai RAAS Blood-derived Products Product Portfolio Table 95. Shanghai RAAS Recent Development Table 96. Hualan Bio Company Information Table 97. Hualan Bio Business Overview Table 98. Hualan Bio Blood-derived Products Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 99. Hualan Bio Blood-derived Products Product Portfolio Table 100. Hualan Bio Recent Development Table 101. Boya Bio Company Information Table 102. Boya Bio Business Overview Table 103. Boya Bio Blood-derived Products Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 104. Boya Bio Blood-derived Products Product Portfolio Table 105. Boya Bio Recent Development Table 106. CBPO Company Information Table 107. CBPO Business Overview Table 108. CBPO Blood-derived Products Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 109. CBPO Blood-derived Products Product Portfolio Table 110. CBPO Recent Development Table 111. Octapharma Company Information Table 112. Octapharma Business Overview Table 113. Octapharma Blood-derived Products Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 114. Octapharma Blood-derived Products Product Portfolio Table 115. Octapharma Recent Development Table 116. LFB Group Company Information Table 117. LFB Group Business Overview Table 118. LFB Group Blood-derived Products Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 119. LFB Group Blood-derived Products Product Portfolio Table 120. LFB Group Recent Development Table 121. Kedrion Company Information Table 122. Kedrion Business Overview Table 123. Kedrion Blood-derived Products Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 124. Kedrion Blood-derived Products Product Portfolio Table 125. Kedrion Recent Development Table 126. Grifols Company Information Table 127. Grifols Business Overview Table 128. Grifols Blood-derived Products Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 129. Grifols Blood-derived Products Product Portfolio Table 130. Grifols Recent Development Table 131. CSL Company Information Table 132. CSL Business Overview Table 133. CSL Blood-derived Products Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 134. CSL Blood-derived Products Product Portfolio Table 135. CSL Recent Development Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Blood-derived Products Distributors List Table 139. Blood-derived Products Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Blood-derived Products Product Image Figure 2. Global Blood-derived Products Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood-derived Products Sales Value (2021-2032) & (US$ Million) Figure 4. Global Blood-derived Products Sales (2021-2032) & (t) Figure 5. Global Blood-derived Products Sales Average Price (USD/kg) & (2021-2032) Figure 6. Global Blood-derived Products Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Coagulation Factors Image Figure 10. Immunoglobulins Image Figure 11. Albumin Image Figure 12. Others Image Figure 13. Global Blood-derived Products Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 14. Global Blood-derived Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Blood-derived Products Sales Volume Share by Type (2021-2032) Figure 16. Global Blood-derived Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Blood-derived Products Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Blood-derived Products Sales Value Share by Type (2021-2032) Figure 19. Therapeutics Image Figure 20. Excipient Image Figure 21. Other Image Figure 22. Global Blood-derived Products Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 23. Global Blood-derived Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Blood-derived Products Sales Volume Share by Application (2021-2032) Figure 25. Global Blood-derived Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Blood-derived Products Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Blood-derived Products Sales Value Share by Application (2021-2032) Figure 28. Global Blood-derived Products Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 29. Global Blood-derived Products Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Blood-derived Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Blood-derived Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Blood-derived Products Sales Value (2021-2032) & (US$ Million) Figure 33. North America Blood-derived Products Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Blood-derived Products Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Blood-derived Products Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Blood-derived Products Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Blood-derived Products Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Blood-derived Products Sales Value (2021-2032) & (US$ Million) Figure 39. South America Blood-derived Products Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Blood-derived Products Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Blood-derived Products Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Blood-derived Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Blood-derived Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Blood-derived Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Blood-derived Products Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Blood-derived Products Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Coagulation Factors
  • Immunoglobulins
  • Albumin
  • Others
Applications
  • Therapeutics
  • Excipient
  • Other
Companies covered
  • Yuanda Shuyang
  • Takeda
  • Weiguang Bio
  • Tiantan Bio
  • Shuanglin Bio
  • Shanghai RAAS
  • Hualan Bio
  • Boya Bio
  • CBPO
  • Octapharma
  • LFB Group
  • Kedrion
  • Grifols
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Blood-derived Products Sales Value (2021-2032)
  4. 1.2.2 Global Blood-derived Products Sales Volume (2021-2032)
  5. 1.2.3 Global Blood-derived Products Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Blood-derived Products Market Dynamics
  1. 2.1 Blood-derived Products Industry Trends
  2. 2.2 Blood-derived Products Industry Drivers
  3. 2.3 Blood-derived Products Industry Opportunities and Challenges
  4. 2.4 Blood-derived Products Industry Restraints
3 Blood-derived Products Market by Company
  1. 3.1 Global Blood-derived Products Company Revenue Ranking in 2025
  2. 3.2 Global Blood-derived Products Revenue by Company (2021-2026)
  3. 3.3 Global Blood-derived Products Sales Volume by Company (2021-2026)
  4. 3.4 Global Blood-derived Products Average Price by Company (2021-2026)
  5. 3.5 Global Blood-derived Products Company Ranking (2024-2026)
  6. 3.6 Global Blood-derived Products Company Manufacturing Base and Headquarters
  7. 3.7 Global Blood-derived Products Company Product Type and Application
  8. 3.8 Global Blood-derived Products Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Blood-derived Products Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Blood-derived Products Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Blood-derived Products Market by Type
  1. 4.1 Blood-derived Products Type Introduction
  2. 4.1.1 Coagulation Factors
  3. 4.1.2 Immunoglobulins
  4. 4.1.3 Albumin
  5. 4.1.4 Others
  6. 4.2 Global Blood-derived Products Sales Volume by Type
  7. 4.2.1 Global Blood-derived Products Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Blood-derived Products Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Blood-derived Products Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Blood-derived Products Sales Value by Type
  11. 4.3.1 Global Blood-derived Products Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Blood-derived Products Sales Value by Type (2021-2032)
  13. 4.3.3 Global Blood-derived Products Sales Value Share by Type (2021-2032)
5 Blood-derived Products Market by Application
  1. 5.1 Blood-derived Products Application Introduction
  2. 5.1.1 Therapeutics
  3. 5.1.2 Excipient
  4. 5.1.3 Other
  5. 5.2 Global Blood-derived Products Sales Volume by Application
  6. 5.2.1 Global Blood-derived Products Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Blood-derived Products Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Blood-derived Products Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Blood-derived Products Sales Value by Application
  10. 5.3.1 Global Blood-derived Products Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Blood-derived Products Sales Value by Application (2021-2032)
  12. 5.3.3 Global Blood-derived Products Sales Value Share by Application (2021-2032)
6 Blood-derived Products Regional Sales and Value Analysis
  1. 6.1 Global Blood-derived Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Blood-derived Products Sales by Region (2021-2032)
  3. 6.2.1 Global Blood-derived Products Sales by Region: 2021-2026
  4. 6.2.2 Global Blood-derived Products Sales by Region (2027-2032)
  5. 6.3 Global Blood-derived Products Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Blood-derived Products Sales Value by Region (2021-2032)
  7. 6.4.1 Global Blood-derived Products Sales Value by Region: 2021-2026
  8. 6.4.2 Global Blood-derived Products Sales Value by Region (2027-2032)
  9. 6.5 Global Blood-derived Products Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Blood-derived Products Sales Value (2021-2032)
  12. 6.6.2 North America Blood-derived Products Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Blood-derived Products Sales Value (2021-2032)
  15. 6.7.2 Europe Blood-derived Products Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Blood-derived Products Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Blood-derived Products Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Blood-derived Products Sales Value (2021-2032)
  21. 6.9.2 South America Blood-derived Products Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Blood-derived Products Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Blood-derived Products Sales Value Share by Country, 2025 VS 2032
7 Blood-derived Products Country-level Sales and Value Analysis
  1. 7.1 Global Blood-derived Products Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Blood-derived Products Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Blood-derived Products Sales by Country (2021-2032)
  4. 7.3.1 Global Blood-derived Products Sales by Country (2021-2026)
  5. 7.3.2 Global Blood-derived Products Sales by Country (2027-2032)
  6. 7.4 Global Blood-derived Products Sales Value by Country (2021-2032)
  7. 7.4.1 Global Blood-derived Products Sales Value by Country (2021-2026)
  8. 7.4.2 Global Blood-derived Products Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Blood-derived Products Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Blood-derived Products Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Blood-derived Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Blood-derived Products Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Blood-derived Products Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Blood-derived Products Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Blood-derived Products Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Blood-derived Products Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Blood-derived Products Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Blood-derived Products Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Blood-derived Products Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Blood-derived Products Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Blood-derived Products Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Blood-derived Products Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Blood-derived Products Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Blood-derived Products Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Blood-derived Products Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Blood-derived Products Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Blood-derived Products Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Blood-derived Products Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Blood-derived Products Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Blood-derived Products Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Blood-derived Products Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Blood-derived Products Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Blood-derived Products Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Blood-derived Products Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Blood-derived Products Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Blood-derived Products Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Blood-derived Products Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Blood-derived Products Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Blood-derived Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yuanda Shuyang
  2. 8.1.1 Yuanda Shuyang Company Information
  3. 8.1.2 Yuanda Shuyang Business Overview
  4. 8.1.3 Yuanda Shuyang Blood-derived Products Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yuanda Shuyang Blood-derived Products Product Portfolio
  6. 8.1.5 Yuanda Shuyang Recent Developments
  7. 8.2 Takeda
  8. 8.2.1 Takeda Company Information
  9. 8.2.2 Takeda Business Overview
  10. 8.2.3 Takeda Blood-derived Products Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Blood-derived Products Product Portfolio
  12. 8.2.5 Takeda Recent Developments
  13. 8.3 Weiguang Bio
  14. 8.3.1 Weiguang Bio Company Information
  15. 8.3.2 Weiguang Bio Business Overview
  16. 8.3.3 Weiguang Bio Blood-derived Products Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Weiguang Bio Blood-derived Products Product Portfolio
  18. 8.3.5 Weiguang Bio Recent Developments
  19. 8.4 Tiantan Bio
  20. 8.4.1 Tiantan Bio Company Information
  21. 8.4.2 Tiantan Bio Business Overview
  22. 8.4.3 Tiantan Bio Blood-derived Products Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Tiantan Bio Blood-derived Products Product Portfolio
  24. 8.4.5 Tiantan Bio Recent Developments
  25. 8.5 Shuanglin Bio
  26. 8.5.1 Shuanglin Bio Company Information
  27. 8.5.2 Shuanglin Bio Business Overview
  28. 8.5.3 Shuanglin Bio Blood-derived Products Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shuanglin Bio Blood-derived Products Product Portfolio
  30. 8.5.5 Shuanglin Bio Recent Developments
  31. 8.6 Shanghai RAAS
  32. 8.6.1 Shanghai RAAS Company Information
  33. 8.6.2 Shanghai RAAS Business Overview
  34. 8.6.3 Shanghai RAAS Blood-derived Products Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai RAAS Blood-derived Products Product Portfolio
  36. 8.6.5 Shanghai RAAS Recent Developments
  37. 8.7 Hualan Bio
  38. 8.7.1 Hualan Bio Company Information
  39. 8.7.2 Hualan Bio Business Overview
  40. 8.7.3 Hualan Bio Blood-derived Products Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hualan Bio Blood-derived Products Product Portfolio
  42. 8.7.5 Hualan Bio Recent Developments
  43. 8.8 Boya Bio
  44. 8.8.1 Boya Bio Company Information
  45. 8.8.2 Boya Bio Business Overview
  46. 8.8.3 Boya Bio Blood-derived Products Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Boya Bio Blood-derived Products Product Portfolio
  48. 8.8.5 Boya Bio Recent Developments
  49. 8.9 CBPO
  50. 8.9.1 CBPO Company Information
  51. 8.9.2 CBPO Business Overview
  52. 8.9.3 CBPO Blood-derived Products Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 CBPO Blood-derived Products Product Portfolio
  54. 8.9.5 CBPO Recent Developments
  55. 8.10 Octapharma
  56. 8.10.1 Octapharma Company Information
  57. 8.10.2 Octapharma Business Overview
  58. 8.10.3 Octapharma Blood-derived Products Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Octapharma Blood-derived Products Product Portfolio
  60. 8.10.5 Octapharma Recent Developments
  61. 8.11 LFB Group
  62. 8.11.1 LFB Group Company Information
  63. 8.11.2 LFB Group Business Overview
  64. 8.11.3 LFB Group Blood-derived Products Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 LFB Group Blood-derived Products Product Portfolio
  66. 8.11.5 LFB Group Recent Developments
  67. 8.12 Kedrion
  68. 8.12.1 Kedrion Company Information
  69. 8.12.2 Kedrion Business Overview
  70. 8.12.3 Kedrion Blood-derived Products Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Kedrion Blood-derived Products Product Portfolio
  72. 8.12.5 Kedrion Recent Developments
  73. 8.13 Grifols
  74. 8.13.1 Grifols Company Information
  75. 8.13.2 Grifols Business Overview
  76. 8.13.3 Grifols Blood-derived Products Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Grifols Blood-derived Products Product Portfolio
  78. 8.13.5 Grifols Recent Developments
  79. 8.14 CSL
  80. 8.14.1 CSL Company Information
  81. 8.14.2 CSL Business Overview
  82. 8.14.3 CSL Blood-derived Products Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 CSL Blood-derived Products Product Portfolio
  84. 8.14.5 CSL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Blood-derived Products Value Chain Analysis
  2. 9.1.1 Blood-derived Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Blood-derived Products Sales Mode & Process
  6. 9.2 Blood-derived Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Blood-derived Products Distributors
  9. 9.2.3 Blood-derived Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst